These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 5577431

  • 1. [Therapeutic results with 1035 MD (apropos of 92 cases)].
    Delteil P, Douche F, Fromentin M.
    Ann Med Psychol (Paris); 1971 Feb; 1(2):261-8. PubMed ID: 5577431
    [No Abstract] [Full Text] [Related]

  • 2. [Restructuring action of Sureptil in anxio-depressive components of involutive states].
    Carrère J.
    Ann Med Psychol (Paris); 1970 Oct; 2(3):409-19. PubMed ID: 5481455
    [No Abstract] [Full Text] [Related]

  • 3. [Action of 1035 M. D. in neuropsychic syndromes of vascular origin and certain involutional psychoses].
    Ey H, Bohard F.
    Ann Med Psychol (Paris); 1967 Dec; 2(5):767-71. PubMed ID: 5585706
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic use of a nicofuranosio-centrophenoxine association in involutive psychoses].
    Viviano M, Ceccarelli G.
    Minerva Med; 1966 Nov 24; 57(94):3965-9. PubMed ID: 4380869
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S, Sère de Rivières H.
    Therapeutique; 1972 Jan 24; 48(1):27-34. PubMed ID: 5046366
    [No Abstract] [Full Text] [Related]

  • 8. [Clinico-statistical evaluation on the use in psycho-geriatrices of fluoxymesterone].
    De Maio D, Ferrazzi D.
    Minerva Med; 1969 Jan 27; 60(8):315-9. PubMed ID: 5766860
    [No Abstract] [Full Text] [Related]

  • 9. [Trial of 1035 MD in a population of mentally retarded subjects in medico-pedagogic institutes].
    Besançon G, Blineau-Vecchierini MF.
    Rev Neuropsychiatr Infant; 1973 Sep 27; 21(9):565-8. PubMed ID: 4586339
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Participation of a new cerebral vasodilator, 1,035 M.D. in the involutional psychoses of chronic alcoholism].
    Ducamin JP, Cron.
    Encephale; 1969 Sep 27; 58(3):283-7. PubMed ID: 5378186
    [No Abstract] [Full Text] [Related]

  • 12. [Dehydrobenzperidol (dbp) in psychiatry: clinical experiences].
    Escalar G, Saccani P.
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug 31; 92(4):1168-92. PubMed ID: 5738065
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L.
    Ther Hung; 1974 Aug 31; 22(1):32-4. PubMed ID: 4844929
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and experimental experience with the nicotinic acid ester 7-oxyethyltheophylline].
    Fischbach R, Haas R.
    Arzneimittelforschung; 1967 Mar 31; 17(3):313-7. PubMed ID: 5631222
    [No Abstract] [Full Text] [Related]

  • 20. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age].
    Giovanardi F, Bisceglia G.
    Clin Ter; 1971 Aug 31; 58(3):243-53. PubMed ID: 5135003
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.